ENTITY
Regeneron Pharmaceuticals

Regeneron Pharmaceuticals (REGN US)

118
Analysis
Health CareUnited States
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.
more
Company Event03 Feb 2026 21:30 • Upcoming
Add To Calendar
Company Event03 Dec 2025 23:30 • Latest
Company Event03 Dec 2025 02:20
Company Event28 Oct 2025 20:30
Company Event01 Aug 2025 20:30
x